ISPIRE TECHNOLOGY INC (ISPR) Fundamental Analysis & Valuation

NASDAQ:ISPRUS46501C1009

Current stock price

1.76 USD
0 (0%)
At close:
1.76 USD
0 (0%)
After Hours:

This ISPR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ISPR Profitability Analysis

1.1 Basic Checks

  • In the past year ISPR has reported negative net income.
  • ISPR had a negative operating cash flow in the past year.
  • ISPR had negative earnings in 4 of the past 5 years.
  • In the past 5 years ISPR reported 4 times negative operating cash flow.
ISPR Yearly Net Income VS EBIT VS OCF VS FCFISPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • ISPR has a Return On Assets of -42.07%. This is amonst the worse of the industry: ISPR underperforms 87.50% of its industry peers.
Industry RankSector Rank
ROA -42.07%
ROE N/A
ROIC N/A
ROA(3y)-19.02%
ROA(5y)-11.16%
ROE(3y)-2183.71%
ROE(5y)-1309.14%
ROIC(3y)N/A
ROIC(5y)N/A
ISPR Yearly ROA, ROE, ROICISPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 -2K -4K -6K

1.3 Margins

  • ISPR has a Gross Margin of 16.37%. This is in the lower half of the industry: ISPR underperforms 75.00% of its industry peers.
  • In the last couple of years the Gross Margin of ISPR has grown nicely.
  • ISPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.56%
GM growth 5YN/A
ISPR Yearly Profit, Operating, Gross MarginsISPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1

2. ISPR Health Analysis

2.1 Basic Checks

  • ISPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ISPR has more shares outstanding than it did 1 year ago.
  • ISPR has a worse debt/assets ratio than last year.
ISPR Yearly Shares OutstandingISPR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ISPR Yearly Total Debt VS Total AssetsISPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • ISPR has an Altman-Z score of -0.47. This is a bad value and indicates that ISPR is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.47, ISPR is doing worse than 62.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.47
ROIC/WACCN/A
WACC9.93%
ISPR Yearly LT Debt VS Equity VS FCFISPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 10M -10M 20M -20M 30M

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that ISPR should not have too much problems paying its short term obligations.
  • The Current ratio of ISPR (1.06) is comparable to the rest of the industry.
  • A Quick Ratio of 0.96 indicates that ISPR may have some problems paying its short term obligations.
  • ISPR has a Quick ratio (0.96) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.96
ISPR Yearly Current Assets VS Current LiabilitesISPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

3

3. ISPR Growth Analysis

3.1 Past

  • The earnings per share for ISPR have decreased strongly by -51.51% in the last year.
  • ISPR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.71%.
  • The Revenue has been growing by 13.11% on average over the past years. This is quite good.
EPS 1Y (TTM)-51.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)-34.71%
Revenue growth 3Y13.11%
Revenue growth 5YN/A
Sales Q2Q%-51.5%

3.2 Future

  • ISPR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.32% yearly.
  • The Revenue is expected to decrease by -13.04% on average over the next years. This is quite bad
EPS Next Y68.96%
EPS Next 2Y39.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-33.85%
Revenue Next 2Y-13.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ISPR Yearly Revenue VS EstimatesISPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ISPR Yearly EPS VS EstimatesISPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.2 -0.4 -0.6

1

4. ISPR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ISPR. In the last year negative earnings were reported.
  • Also next year ISPR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ISPR Price Earnings VS Forward Price EarningsISPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ISPR Per share dataISPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • ISPR's earnings are expected to grow with 39.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.32%
EPS Next 3YN/A

0

5. ISPR Dividend Analysis

5.1 Amount

  • ISPR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ISPR Fundamentals: All Metrics, Ratios and Statistics

ISPIRE TECHNOLOGY INC

NASDAQ:ISPR (3/23/2026, 5:20:02 PM)

After market: 1.76 0 (0%)

1.76

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)02-06
Earnings (Next)05-11
Inst Owners8.53%
Inst Owner Change-0.26%
Ins Owners4.18%
Ins Owner Change5.57%
Market Cap100.83M
Revenue(TTM)96.97M
Net Income(TTM)-35.51M
Analysts82.86
Price Target6.63 (276.7%)
Short Float %3.52%
Short Ratio9.05
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-517.65%
Min EPS beat(2)-1076.47%
Max EPS beat(2)41.18%
EPS beat(4)1
Avg EPS beat(4)-293.15%
Min EPS beat(4)-1076.47%
Max EPS beat(4)41.18%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-35.08%
Min Revenue beat(2)-39.37%
Max Revenue beat(2)-30.8%
Revenue beat(4)0
Avg Revenue beat(4)-35.49%
Min Revenue beat(4)-52.54%
Max Revenue beat(4)-19.25%
Revenue beat(8)2
Avg Revenue beat(8)-23.7%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-100%
EPS NY rev (1m)-162.5%
EPS NY rev (3m)-162.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-36.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-29.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS1.69
BVpS-0.13
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -42.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.37%
FCFM N/A
ROA(3y)-19.02%
ROA(5y)-11.16%
ROE(3y)-2183.71%
ROE(5y)-1309.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.56%
GM growth 5YN/A
F-Score3
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 144.99%
Cap/Sales 1.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.96
Altman-Z -0.47
F-Score3
WACC9.93%
ROIC/WACCN/A
Cap/Depr(3y)1019.5%
Cap/Depr(5y)849.8%
Cap/Sales(3y)1.52%
Cap/Sales(5y)0.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y68.96%
EPS Next 2Y39.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.71%
Revenue growth 3Y13.11%
Revenue growth 5YN/A
Sales Q2Q%-51.5%
Revenue Next Year-33.85%
Revenue Next 2Y-13.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-60.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.65%
OCF growth 3YN/A
OCF growth 5YN/A

ISPIRE TECHNOLOGY INC / ISPR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ISPIRE TECHNOLOGY INC (ISPR) stock?

ChartMill assigns a fundamental rating of 1 / 10 to ISPR.


What is the valuation status of ISPIRE TECHNOLOGY INC (ISPR) stock?

ChartMill assigns a valuation rating of 1 / 10 to ISPIRE TECHNOLOGY INC (ISPR). This can be considered as Overvalued.


Can you provide the profitability details for ISPIRE TECHNOLOGY INC?

ISPIRE TECHNOLOGY INC (ISPR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ISPR stock?

The Earnings per Share (EPS) of ISPIRE TECHNOLOGY INC (ISPR) is expected to grow by 68.96% in the next year.